Article Versions Notes

Giuffrida P, Celsa C, Antonucci M, Peri M, Grassini MV, Rancatore G, Giacchetto CM, Cannella R, Incorvaia L, Corsini LR, et al. The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints. Biomedicines. 2022; 10(11):2827. https://doi.org/10.3390/biomedicines10112827

Giuffrida, Paolo, Ciro Celsa, Michela Antonucci, Marta Peri, Maria Vittoria Grassini, Gabriele Rancatore, Carmelo Marco Giacchetto, Roberto Cannella, Lorena Incorvaia, Lidia Rita Corsini, and et al. 2022. "The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints" Biomedicines 10, no. 11: 2827. https://doi.org/10.3390/biomedicines10112827

Giuffrida, P., Celsa, C., Antonucci, M., Peri, M., Grassini, M. V., Rancatore, G., Giacchetto, C. M., Cannella, R., Incorvaia, L., Corsini, L. R., Morana, P., La Mantia, C., Badalamenti, G., Brancatelli, G., Cammà, C., & Cabibbo, G. (2022). The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints. Biomedicines, 10(11), 2827. https://doi.org/10.3390/biomedicines10112827